THE REAL EXPERIENCE OF REACHING AN EXTREMELY LOW LDL-C LEVEL IN HIGH RISK PATIENTS

被引：0
|
作者：
Korneva, V. A. [1 ]
Kuznetsova, T. [1 ]
机构：
[1] Petrozavodsk State Univ, Fac Therapy, Petrozavodsk, Russia
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP276
引用
收藏
页码：E175 / E175
页数：1
相关论文
共 50 条
  • [21] Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study
    Xu, Jie
    Chen, Zimo
    Wang, Meng
    Mo, Jinglin
    Jing, Jing
    Yalkun, Gulbahram
    Dai, Liye
    Meng, Xia
    Li, Hao
    Li, Zixiao
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2023, 8 (02) : 127 - 133
  • [22] Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias
    Vrablik, Michal
    Sarkanova, Ivana
    Brecikova, Katarina
    Sedova, Petra
    Satny, Martin
    Tichopad, Ales
    PLOS ONE, 2023, 18 (05):
  • [23] LDL-C: lower is better for longer-even at low risk
    Penson, Peter E.
    Pirro, Matteo
    Banach, Maciej
    BMC MEDICINE, 2020, 18 (01)
  • [24] Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US
    Marrett, Elizabeth
    Zhao, Changgeng
    Zhang, Ning Jackie
    Zhang, Qiaoyi
    Ramey, Dena R.
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    Neff, David R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 237 - 246
  • [25] LACKING OBSERVANCE OF THE GUIDELINES ON DYSLIPIDAEMIAS AS POSSIBLE REASON FOR LOW LDL-C GOAL ATTAINMENT IN PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK
    Mullerova, J.
    Vrablik, M.
    Sarkanova, I
    Brecikova, K.
    Tichopad, A.
    VALUE IN HEALTH, 2022, 25 (12) : S275 - S275
  • [26] Fluvastatin additional benefit beyond LDL-C reduction: A comparison of cardiovascular events risk in patients with the same level of on treatment LDL
    Bogaerts, K
    Tsonaka, S
    Rizopoulous, D
    Lessafre, E
    Gimpelevvicz, C
    Logan, JO
    Bortolini, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 99 - 99
  • [27] Benefits of Resting Heart Rate Reduction in Patients with Coronary Artery Disease and Low LDL-C level
    Yao, Fengjuan
    Huang, Huiling
    Ye, Min
    Ma, Hong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C121 - C121
  • [28] Carotid plaque to predict the presence of coronary artery stenosis in a patient with extremely low LDL-C
    Park, Yae Min
    Koh, Kwang Kon
    Han, Seung Hwan
    Yu, Seung-Hee
    Kang, Woong Chol
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (01) : E3 - E4
  • [29] 'LDL-C' = LDL-C plus Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering
    Yeang, Calvin
    Witztum, Joseph L.
    Tsimikas, Sotirios
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) : 169 - 178
  • [30] UNDERSTANDING THE PREDICTORS OF ACHIEVING LDL-C TARGETS WHEN ADDING EZETIMIBE IN HIGH RISK PATIENTS
    Karalis, Dean
    Mallya, Usha
    Elassal, Joseph
    Ghannam, Ameen F.
    Gupta, Rishab
    Boklage, Susan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1703 - 1703
12345